Methyl 7-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate

Catalog No.: 
ACVFCG519
CAS No.: 
1363382-48-2
Molecular Formula: 
C8H6BrN3O2
Molecular Weight: 
256.06
Methyl 7-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$446.00InquiryInquiry
250mg95%$871.00InquiryInquiry
1g95%$3414.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 7-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate
IUPAC Namemethyl 7-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate
Molecular FormulaC8H6BrN3O2
Molecular Weight256.06
SMILESO=C(C1=C2N=CC=C(Br)N2N=C1)OC
InChI KeyHOIJXPXRCYDASI-UHFFFAOYSA-N
SynonymEthyl 7-broMopyrazolo[1,5-a]pyriMidine-3-carboxylate;Methyl 7-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate;7-Bromo-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid ethyl ester;Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 7-bromo-, methyl ester
CAS No.1363382-48-2

Synthetic Route by SureRoute

1. ACVFCG519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVFCG519 route product structure diagram
    ACVFCG5191363382-48-2
Inquiry

2. ACVFCG519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVFCG519 route product structure diagram
    ACVFCG5191363382-48-2
Inquiry

3. ACVFCG519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVFCG519 route product structure diagram
    ACVFCG5191363382-48-2
Inquiry

Comments (0)